source
- Sanofi gains FDA clearance for Gaucher disease pillThe approval culminates a winding development journey for Infilbray, and provides Sanofi with a new source of income ahead of Dupixent’s looming patent expiration.BioPharma Dive · 1h ago↗ source
- Lilly starts work on Pennsylvania obesity plant; ITM, AtomVie strike supply dealLilly breaks ground in Pennsylvania: Eli Lilly has started construction on its $3.5 billion factory in Lehigh Valley, PA, which will manufacture obesity drugs including Lilly’s retatrutide. The sit…Endpoints · 1h ago↗ source
- STAT+: Lawmakers want U.S. biotech to outcompete ChinaLawmakers leading the congressional BIOTech Caucus say Washington needs to act in the sector — and fast:STAT · 1h ago